JP2022523047A5 - - Google Patents
Info
- Publication number
- JP2022523047A5 JP2022523047A5 JP2021543183A JP2021543183A JP2022523047A5 JP 2022523047 A5 JP2022523047 A5 JP 2022523047A5 JP 2021543183 A JP2021543183 A JP 2021543183A JP 2021543183 A JP2021543183 A JP 2021543183A JP 2022523047 A5 JP2022523047 A5 JP 2022523047A5
- Authority
- JP
- Japan
- Prior art keywords
- sequence number
- human
- antigen
- antibody
- cdr1
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP19305086 | 2019-01-23 | ||
| EP19305086.1 | 2019-01-23 | ||
| PCT/EP2020/051667 WO2020152290A1 (en) | 2019-01-23 | 2020-01-23 | Cd31 competitors and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022523047A JP2022523047A (ja) | 2022-04-21 |
| JP2022523047A5 true JP2022523047A5 (https=) | 2023-02-01 |
Family
ID=65409014
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021543183A Pending JP2022523047A (ja) | 2019-01-23 | 2020-01-23 | Ｃｄ３１競合剤およびその使用 |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US20220089765A1 (https=) |
| EP (1) | EP3914616A1 (https=) |
| JP (1) | JP2022523047A (https=) |
| KR (1) | KR20210119448A (https=) |
| CN (1) | CN113614107A (https=) |
| AU (1) | AU2020211728A1 (https=) |
| BR (1) | BR112021014574A2 (https=) |
| CA (1) | CA3127520A1 (https=) |
| IL (1) | IL284962A (https=) |
| MX (1) | MX2021008672A (https=) |
| SG (1) | SG11202107941TA (https=) |
| WO (1) | WO2020152290A1 (https=) |
| ZA (1) | ZA202105154B (https=) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP3943505A1 (en) | 2020-07-22 | 2022-01-26 | Encefa | Cd38-binding cd31 peptides and uses thereof |
| CN117567594B (zh) * | 2023-11-30 | 2025-02-07 | 北京博奥森生物技术有限公司 | 一种模拟cd31线性分子抗原性的分支多肽制备方法 |
Family Cites Families (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| IL85035A0 (en) | 1987-01-08 | 1988-06-30 | Int Genetic Eng | Polynucleotide molecule,a chimeric antibody with specificity for human b cell surface antigen,a process for the preparation and methods utilizing the same |
| DE69120146T2 (de) | 1990-01-12 | 1996-12-12 | Cell Genesys Inc | Erzeugung xenogener antikörper |
| US6673986B1 (en) | 1990-01-12 | 2004-01-06 | Abgenix, Inc. | Generation of xenogeneic antibodies |
| US6150584A (en) | 1990-01-12 | 2000-11-21 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| US6075181A (en) | 1990-01-12 | 2000-06-13 | Abgenix, Inc. | Human antibodies derived from immunized xenomice |
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| DE19742706B4 (de) | 1997-09-26 | 2013-07-25 | Pieris Proteolab Ag | Lipocalinmuteine |
| ATE375365T1 (de) | 1998-04-02 | 2007-10-15 | Genentech Inc | Antikörper varianten und fragmente davon |
| PL209392B1 (pl) | 1999-01-15 | 2011-08-31 | Genentech Inc | Przeciwciało, komórka gospodarza, sposób wytwarzania przeciwciała oraz zastosowanie przeciwciała |
| CA2704600C (en) | 1999-04-09 | 2016-10-25 | Kyowa Kirin Co., Ltd. | A method for producing antibodies with increased adcc activity |
| FR2807767B1 (fr) | 2000-04-12 | 2005-01-14 | Lab Francais Du Fractionnement | Anticorps monoclonaux anti-d |
| CA2430013C (en) | 2000-11-30 | 2011-11-22 | Medarex, Inc. | Transgenic transchromosomal rodents for making human antibodies |
| US7083784B2 (en) | 2000-12-12 | 2006-08-01 | Medimmune, Inc. | Molecules with extended half-lives, compositions and uses thereof |
| US20040002587A1 (en) | 2002-02-20 | 2004-01-01 | Watkins Jeffry D. | Fc region variants |
| EP1553975B8 (en) | 2002-09-27 | 2023-04-12 | Xencor, Inc. | Optimized fc variants and methods for their generation |
| CA2512729C (en) | 2003-01-09 | 2014-09-16 | Macrogenics, Inc. | Identification and engineering of antibodies with variant fc regions and methods of using same |
| CA2625681C (en) * | 2005-10-12 | 2016-08-02 | Morphosys Ag | Generation and profiling of fully human hucal gold-derived therapeutic antibodies specific for human cd38 |
| KR20140133958A (ko) | 2005-10-21 | 2014-11-20 | 엘에프비 유에스에이, 인크. | 항체 의존성 세포 독성 활성이 증강된 항체, 그 생산 및 사용 방법 |
| EP1930342B1 (en) | 2006-12-04 | 2012-01-25 | Institut Pasteur | OB-fold used as scaffold for engineering new specific binders |
| PL2602323T3 (pl) | 2007-06-01 | 2018-06-29 | Open Monoclonal Technology, Inc. | Kompozycje i sposoby hamowania endogennych genów immunoglobin i wytwarzania transgenicznych ludzkich przeciwciał typu idiotypowego |
| JP5913980B2 (ja) | 2008-10-14 | 2016-05-11 | ジェネンテック， インコーポレイテッド | 免疫グロブリン変異体及びその用途 |
| EP2233500A1 (en) | 2009-03-20 | 2010-09-29 | LFB Biotechnologies | Optimized Fc variants |
| US20120258496A1 (en) | 2010-09-27 | 2012-10-11 | Boehringer Ingelheim International Gmbh | Production of low fucose antibodies in h4-ii-e rat cells |
| JOP20210044A1 (ar) * | 2010-12-30 | 2017-06-16 | Takeda Pharmaceuticals Co | الأجسام المضادة لـ cd38 |
| FR3003171B1 (fr) | 2013-03-15 | 2015-04-10 | Lab Francais Du Fractionnement | Nouveaux medicaments comprenant une composition d'anticorps enrichie en isoforme de charge majoritaire |
| US20150093399A1 (en) | 2013-08-28 | 2015-04-02 | Bioasis Technologies, Inc. | Cns-targeted conjugates having modified fc regions and methods of use thereof |
| MA40894A (fr) * | 2014-11-04 | 2017-09-12 | Glenmark Pharmaceuticals Sa | Immunoglobulines hétéro-dimères reciblant des lymphocytes t cd3/cd38 et leurs procédés de production |
| EA039366B1 (ru) | 2015-06-24 | 2022-01-19 | Джей Си Ар ФАРМАСЬЮТИКАЛЗ КО., ЛТД. | Антитело к рецептору трансферрина человека, проникающее через гематоэнцефалический барьер |
| CN110997722B (zh) * | 2017-06-08 | 2023-09-26 | 黑带医疗有限公司 | Cd38调节抗体 |
-
2020
- 2020-01-23 SG SG11202107941TA patent/SG11202107941TA/en unknown
- 2020-01-23 CN CN202080023098.6A patent/CN113614107A/zh active Pending
- 2020-01-23 MX MX2021008672A patent/MX2021008672A/es unknown
- 2020-01-23 CA CA3127520A patent/CA3127520A1/en active Pending
- 2020-01-23 US US17/425,022 patent/US20220089765A1/en not_active Abandoned
- 2020-01-23 AU AU2020211728A patent/AU2020211728A1/en not_active Abandoned
- 2020-01-23 JP JP2021543183A patent/JP2022523047A/ja active Pending
- 2020-01-23 EP EP20701759.1A patent/EP3914616A1/en not_active Withdrawn
- 2020-01-23 WO PCT/EP2020/051667 patent/WO2020152290A1/en not_active Ceased
- 2020-01-23 BR BR112021014574-5A patent/BR112021014574A2/pt not_active IP Right Cessation
- 2020-01-23 KR KR1020217026266A patent/KR20210119448A/ko not_active Ceased
-
2021
- 2021-07-19 IL IL284962A patent/IL284962A/en unknown
- 2021-07-21 ZA ZA2021/05154A patent/ZA202105154B/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP7027482B2 (ja) | Ｇタンパク質共役受容体を標的化する抗体および使用の方法 | |
| JP7823118B2 (ja) | α－シヌクレインに対する抗体およびその使用 | |
| JP7019198B2 (ja) | 補体関連疾患の予防及び治療のためのｃ５抗体及び方法 | |
| WO2021104053A1 (zh) | 一种tslp相关病症治疗剂的开发和应用 | |
| JP6400480B2 (ja) | ペプチドグリカン認識タンパク質１に結合する抗体 | |
| JP2018138035A (ja) | 静電的ステアリング（ｅｌｅｃｔｒｏｓｔａｔｉｃ ｓｔｅｅｒｉｎｇ）効果を用いた抗体Ｆｃヘテロ二量体分子を作製するための方法 | |
| TW201833141A (zh) | 抗b7-h3抗體、其抗原結合片段及其醫藥用途 | |
| CN111320693B (zh) | 抗EphA4抗体 | |
| RU2004121673A (ru) | Человеческие полипептиды, вызывающие или опосредующие лизис клеток, включая клетки лимфоидных опухолей | |
| CN113906050B (zh) | 抗EphA4抗体 | |
| KR20120056800A (ko) | 글루글루카곤 수용체에 대한 항체와 이의 사용 | |
| WO2019228405A1 (zh) | 一种自免疫抑制剂及其应用 | |
| JP2022542884A5 (https=) | ||
| JP2025134864A5 (https=) | ||
| JP2022523047A5 (https=) | ||
| WO2016119523A1 (zh) | 全人源her2抗体的突变抗体及其编码基因和应用 | |
| RU2021124077A (ru) | Конкурент за связывание с антителом CD31 и его применение | |
| JP7839108B2 (ja) | 筋萎縮性側索硬化症の治療用医薬組成物 | |
| JP7796049B2 (ja) | 抗ＥｐｈＡ４抗体 | |
| RU2816371C2 (ru) | АНТИТЕЛО К EphA4 | |
| TW202328194A (zh) | Ｌｉｌｒｂ２特異性單株抗體及其使用方法 | |
| KR20100021657A (ko) | 프로테아제 활성화된 수용체-１ (ｐａｒ１)의 길항제 항체 | |
| JP2024541576A (ja) | 新規特異的アンタゴニスト抗ＳＩＲＰｇ抗体 | |
| HK40105878A (zh) | 新的抗masp-2抗体 | |
| CN119585311A (zh) | 结合大麻素受体cb1的抗体及其用途 |